Drugs / autologous adipose-derived mesenchymal stem cell spheroid
autologous adipose-derived mesenchymal stem cell spheroid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05011474 | Apr 2021 → Jan 2022 | lumbar disk degenerative disorder | Inbo Han | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous adipose-derived mesenchymal stem cell spheroid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05011474 ↗ |
| Modality | Cell therapy | “Adipose-derived mesenchymal stem cells isolated from subject's adipose tissue are pretreated with matrillin 3 and produced in spheroid form.” NCT05011474 ↗ |